0.86 USD
+0.06 (+7.5%)
0.8719 USD
+0.01 (+1.38%)
ChartMill assigns a Buy % Consensus number of 83% to ACRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.72. This target is 448.55% above the current price.
ACRX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACRX.
In the previous month the buy percentage consensus was at a similar level.
ACRX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-02 | Alliance Global Partners | Initiate | Buy |
| 2023-09-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-18 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2021-08-17 | HC Wainwright & Co. | Maintains | Buy |
ACELRX PHARMACEUTICALS INC / ACRX FAQ
Can you provide the average price target for ACELRX PHARMACEUTICALS INC stock?
8 analysts have analysed ACRX and the average price target is 4.72 USD. This implies a price increase of 448.55% is expected in the next year compared to the current price of 0.86.
What is the consensus rating for ACELRX PHARMACEUTICALS INC (ACRX) stock?
The consensus rating for ACELRX PHARMACEUTICALS INC (ACRX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ACRX stock?
The number of analysts covering ACELRX PHARMACEUTICALS INC (ACRX) is 8.